Source: International Congress 2017 – CAP: severity scores, risk groups and biomarkers
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
E. Seref Parlak (Ankara, Turkey). Evaluation of thiol/disulfide redox status in community-acquired pneumonia. 4107

Member's Comments

No comment yet.

Related content which might interest you: Biomarkers and clinical stability in community-acquired pneumonia Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers Year: 2009 Estimation of inflammatory process activity in community-acquired pneumonia Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations Year: 2010 Quality indicators for management of community-acquired pneumonia Source: International Congress 2015 – Healthcare organisation and appropriateness in lung disorders Year: 2015 Features of peroxide lipids oxidation in patients with community-acquired pneumonia in Belarus prisons Source: Eur Respir J 2006; 28: Suppl. 50, 1s Year: 2006 Predicting Mycobacterium tuberculosis in patients with community-acquired pneumonia Source: Eur Respir J 2014; 43: 178-184 Year: 2004 Pathogens influence MMP-TIMP imbalance in nosocomial pneumonia Source: Eur Respir J 2001; 18: Suppl. 33, 194s Year: 2001 Relationship between etiologic diagnosis and prognosis in community-acquired pneumonia Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants Year: 2015 Risk factors for pulmonary tuberculosis in community-acquired pneumonia Source: Eur Respir J 2014; 43: 1213 Year: 2014 Risk factors for pulmonary tuberculosis in community-acquired pneumonia Source: Eur Respir J 2014; 43: 1214 Year: 2014 Studying of psychical adaptation features and peroxide lipids oxidation in patients suffering from community-acquired pneumonia in Belarus prisons Source: Eur Respir J 2006; 28: Suppl. 50, 375s Year: 2006 Impact of aspiration pneumonia in community-acquired pneumonia and healthcare-associated pneumonia Source: Annual Congress 2012 - CT findings: educational posters Year: 2012 Severity assessment of healthcare-associated pneumonia and pneumonia in immunosuppression Source: Eur Respir J 2012; 40: 1201-1210 Year: 2012 Peculiarities of community-acquired pneumonia in tobacco-smoking patients Source: Annual Congress 2009 - Tobacco: from smoke to disease Year: 2009 Relation between bacteremia and septic shock in patients with pneumococcal community-acquired pneumonia Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections Year: 2013 Glutathione level in community-acquired pneumonia patients. Source: International Congress 2017 – Infection and exacerbation science Year: 2017 Preventing community-acquired pneumonia Source: International Congress 2019 – Respiratory infections: prevention is better than cure Year: 2019 Cardiovascular consequences of community-acquired pneumonia and other pulmonary infections Source: Eur Respir Monogr 2020; 88: 212-228 Year: 2020 Biomarkers and severity in community-acquired pneumonia (CAP) Source: Annual Congress 2012 - Prognostic indices in respiratory infections Year: 2012